Cardiomyocytes derived from iPS cells from a Brugada syndrome patient with a mutation in SCN5A recapitulate the loss of function of the sodium channel current associated with this syndrome, including pro-arrhythmic changes in channel function that could only be detected using iPS-CM and not in conventional heterologous expression systems. Here, SCN5A is linked to Brugada syndrome.